Skip to content

Merck & Co. MRK Accounts Payable

Accounts Payable at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$4.23B+5.8%
Pfizer logo
PfizerPFE
$4.51B-14.0%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$9.22B-2.5%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$1.03B+45.6%
Cytokinetics logo
CytokineticsCYTK
$24.71M+77.2%
Phibro Animal Health logo
Phibro Animal HealthPAHC
$129.64M-1.5%

Other financials

Income statement

See full
Revenue$16.3B+4.9%
Gross profit$12.1B-0.2%
Net income-$4.2B-183%
EPS (diluted)-$1.72-186%

Balance sheet

See full
Cash & equivalents$5.4B-38.2%
Total debt$49.1B+35.8%
Total equity$45.9B-5.1%
Total assets$128.69B+11.8%

Cash flow

See full
Operating cash flow$3.9B+56.7%
CapEx$991.0M-25.4%
Free cash flow$2.9B+150%

Valuation

See full
Market cap$314.83B+52.6%
Enterprise value$358.53B+52.5%
P/E35.2×+22.7×
P/S4.8×+1.5×

Profitability

See full
Gross margin73.9%-2.5pp
Net margin13.6%-13.7pp
FCF margin21.5%-5.2pp

Returns & leverage

See full
Return on equity19%-20.3pp
Debt / equity1.1×+0.3×
Current ratio1.3×-0.1×

Where this comes from

Reported directly by Merck & Co. in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Merck & Co.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merck & Co.'s accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merck & Co.'s accounts payable?
Merck & Co. (MRK) reported accounts payable of $3.86B in Q1 2026.
How has Merck & Co.'s accounts payable changed year-over-year?
Merck & Co.'s accounts payable increased by 2.1% year-over-year, from $3.78B to $3.86B.
What is the long-term trend for Merck & Co.'s accounts payable?
Over 5 years (2020 to 2025), Merck & Co.'s accounts payable has grown at a 0.4% compound annual growth rate (CAGR), from $4.33B to $4.4B.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.